Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Results of PHLawFlu conference to be presented at the European Parliament in Brussels

The results of a three-year research project into pandemic flu preparedness in Europe will be launched at a meeting in Brussels in September. The results of the PHLawFlu (Public Health Law Flu) conference, Pandemic Influenza Preparedness in Europe: Are National Public Health Laws Fit for Purpose? will be presented by Professor Richard Coker, Professor of Public Health at the London School of Hygiene & Tropical Medicine on 23 September at the European Parliament in Brussels.

3 Sep 2010

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration. The application requests authorization to manufacture and market generic versions of REVLIMID (lenalidomide) 5, 10, 15 and 25 mg capsules in the United States.

3 Sep 2010

First Edition: September 3, 2010

Today's headlines contain reports on a new study showing that employers are shifting the increasing costs of premiums onto workers, efforts to get Congress to weigh in on the controversy about federal funding on stem cell research and the difficulty getting uninsured children enrolled in state Medicaid and CHIP programs.

3 Sep 2010

Regional Director of WHO Africa warns of impact global financial situation will have on health systems, MDGs

Regional Director of WHO for Africa Luis Sambo discussed during the 60th session of the Africa Committee of the WHO how the global economic situation could impact funding for health programs in Africa and the ability for countries to reach U.N. Millennium Development Goal targets, PANA/Afrique en ligne reports.

3 Sep 2010

American Cancer Society attacks electronic cigarettes while number of users increase

The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week. Despite the ACS's claims, e cigarette reviews by consumers are still flooding in all over the Internet that smokers who are switching to e cigarettes and e liquid are breathing, tasting, and sleeping better than they ever did while smoking traditional cigarettes.

3 Sep 2010

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

A cell devotes a significant amount of effort to maintaining the stability of its genome, preventing the sorts of chromosomal rearrangements characteristic of many cancers. Assays that measure the rate of gross chromosomal rearrangements (GCRs) are needed in order to understand the individual genes and the different pathways that suppress genomic instability.

3 Sep 2010

St. Jude Doctors and scientists work together to improve survival rates for childhood cancer

Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading cause of death due to disease among U.S. children older than 1 year of age.

3 Sep 2010

Studies show diagnostic errors cause adverse events than medication errors

Studies show that diagnostic errors cause twice as many adverse events as medication errors, but the subject has received little attention; Pennsylvania Patient Safety Authority reviews 100 events related to diagnostic error.

3 Sep 2010

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.

2 Sep 2010

Neutralizing key toxin associated with Staph aureus bacteria reduces severity of skin and soft-tissue damage

Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States.

2 Sep 2010

Quidel's RapidVue hCG lateral flow pregnancy immunoassay granted FDA 510(k) clearance

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of Quidel's RapidVue® hCG test, a lateral flow pregnancy immunoassay for the qualitative detection of human Chorionic Gonadotropin (hCG).

2 Sep 2010

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it was included in a report of President Obama's Council of Advisors on Science and Technology entitled "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza", which was released earlier this month. U.S. Health and Human Services Secretary Kathleen Sebelius and other public health officials held a briefing to discuss this report and the $2 billion plan to accelerate the development of drugs and vaccines to prevent the spread of infectious diseases.

31 Aug 2010

Mandatory influenza vaccination for healthcare personnel needed

Influenza vaccination of healthcare personnel is a professional and ethical responsibility and non-compliance with healthcare facility policies regarding vaccination should not be tolerated, according to a position paper released today by the Society for Healthcare Epidemiology of America (SHEA).

31 Aug 2010

Ralphs Grocery Company to offer seasonal flu vaccine at $25

Ralphs Grocery Company is making it easy and affordable for customers to stay healthy by getting seasonal flu immunizations early.

31 Aug 2010

Salmonella contamination drives retail sales of pasteurized shell eggs

Consumer demand for safe eggs has driven retail sales of pasteurized shell eggs up by more than 50% since Aug. 16 when the Food and Drug Administration (FDA) recommended their use to prevent illness from egg-related Salmonella Enteritidis, announced National Pasteurized Eggs (NPE).

31 Aug 2010

BARDA awards $27 million contract to Achaogen for antibiotic development

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to develop an antibiotic that could be used against possibly two types of bioterrorism as well as common infections that are becoming resistant to antibiotics.

31 Aug 2010

Achaogen receives contract from BARDA for developing ACHN-490 antibiotic treatment

Achaogen, a biopharmaceutical company discovering and developing innovative antibiotics to treat life-threatening, multi-drug resistant (MDR) bacterial infections, today announced the award of a contract with The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.

31 Aug 2010

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.

30 Aug 2010

Children, teens need good health before the start of new school year, says medical director

With the back to school shopping season in full swing, it is also important to arm area children and teens with other tools they need to have a good school year- like medical exams. These are critical to good health and should take place before or shortly after the start of the new school year, and include a routine doctor's exam to confirm that all immunizations are up-to-date, a dental check-up, and a vision exam.

30 Aug 2010

Scientists develop microarray technology to create blood transcriptional signatures for infectious diseases

It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the August 19 issue of Nature and conducted by doctors and researchers at Nationwide Children's Hospital using blood profiling techniques to understand infections.

30 Aug 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Results of PHLawFlu conference to be presented at the European Parliament in Brussels

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

First Edition: September 3, 2010

Regional Director of WHO Africa warns of impact global financial situation will have on health systems, MDGs

American Cancer Society attacks electronic cigarettes while number of users increase

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

St. Jude Doctors and scientists work together to improve survival rates for childhood cancer

Studies show diagnostic errors cause adverse events than medication errors

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Neutralizing key toxin associated with Staph aureus bacteria reduces severity of skin and soft-tissue damage

Quidel's RapidVue hCG lateral flow pregnancy immunoassay granted FDA 510(k) clearance

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Mandatory influenza vaccination for healthcare personnel needed

Ralphs Grocery Company to offer seasonal flu vaccine at $25

Salmonella contamination drives retail sales of pasteurized shell eggs

BARDA awards $27 million contract to Achaogen for antibiotic development

Achaogen receives contract from BARDA for developing ACHN-490 antibiotic treatment

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Children, teens need good health before the start of new school year, says medical director

Scientists develop microarray technology to create blood transcriptional signatures for infectious diseases

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in